$143.22
4.733.42%
At close: -
$143.22
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Charles River Analyst Ratings and Price Targets | NYSE:CRL | Benzinga
Charles River Laboratories International Inc has a consensus price target of $207.4 based on the ratings of 23 analysts. The high is $290 issued by Deutsche Bank on July 14, 2022. The low is $140 issued by Baird on May 8, 2025. The 3 most-recent analyst ratings were released by Redburn Atlantic, Barclays, and Baird on May 23, 2025, May 8, 2025, and May 8, 2025, respectively. With an average price target of $159 between Redburn Atlantic, Barclays, and Baird, there's an implied 11.02% upside for Charles River Laboratories International Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Redburn Atlantic
Barclays
Baird
Mizuho
Goldman Sachs
1calculated from analyst ratings
Analyst Ratings for Charles River
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/23/2025 | Buy Now | 27.08% | Redburn Atlantic | Jamie Clark44% | $188 → $182 | Upgrade | Neutral → Buy | Get Alert |
| 05/08/2025 | Buy Now | 8.23% | Barclays | Luke Sergott51% | $145 → $155 | Maintains | Equal-Weight | Get Alert |
| 05/08/2025 | Buy Now | -2.25% | Baird | Eric Coldwell80% | $118 → $140 | Maintains | Neutral | Get Alert |
| 04/10/2025 | Buy Now | 1.24% | Barclays | Luke Sergott51% | $160 → $145 | Maintains | Equal-Weight | Get Alert |
| 04/09/2025 | Buy Now | 8.23% | Mizuho | Ann Hynes85% | $175 → $155 | Maintains | Neutral | Get Alert |
| 03/21/2025 | Buy Now | 18.7% | Goldman Sachs | Matthew Sykes62% | $190 → $170 | Downgrade | Buy → Neutral | Get Alert |
| 03/04/2025 | Buy Now | 22.19% | Citigroup | Patrick Donnelly80% | $155 → $175 | Upgrade | Sell → Neutral | Get Alert |
| 02/20/2025 | Buy Now | 15.21% | JP Morgan | Casey Woodring27% | $175 → $165 | Maintains | Neutral | Get Alert |
| 02/20/2025 | Buy Now | 20.79% | Baird | Eric Coldwell80% | $177 → $173 | Maintains | Neutral | Get Alert |
| 02/20/2025 | Buy Now | 11.72% | Barclays | Luke Sergott51% | $166 → $160 | Maintains | Equal-Weight | Get Alert |
| 02/18/2025 | Buy Now | 15.91% | Barclays | Luke Sergott51% | $205 → $166 | Maintains | Equal-Weight | Get Alert |
| 02/05/2025 | Buy Now | 28.47% | Morgan Stanley | Ricky Goldwasser79% | $220 → $184 | Maintains | Equal-Weight | Get Alert |
| 02/03/2025 | Buy Now | 22.19% | JP Morgan | Casey Woodring27% | $215 → $175 | Maintains | Neutral | Get Alert |
| 01/23/2025 | Buy Now | 32.66% | Goldman Sachs | Matthew Sykes62% | $220 → $190 | Maintains | Buy | Get Alert |
| 01/22/2025 | Buy Now | — | William Blair | Max Smock23% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/17/2025 | Buy Now | 29.17% | UBS | Dan Leonard54% | $250 → $185 | Downgrade | Buy → Neutral | Get Alert |
| 01/14/2025 | Buy Now | — | William Blair | Max Smock23% | — | Reiterates | Outperform → Outperform | Get Alert |
| 12/13/2024 | Buy Now | 46.63% | B of A Securities | Derik De Bruin84% | $220 → $210 | Maintains | Neutral | Get Alert |
| 11/11/2024 | Buy Now | 58.5% | TD Cowen | Charles Rhyee36% | $203 → $227 | Maintains | Hold | Get Alert |
| 11/07/2024 | Buy Now | 74.56% | UBS | Dan Brennan62% | $240 → $250 | Maintains | Buy | Get Alert |
| 11/07/2024 | Buy Now | 57.1% | Evercore ISI Group | Ross Muken52% | $190 → $225 | Maintains | In-Line | Get Alert |
| 10/23/2024 | Buy Now | 16.6% | CLSA | — | → $167 | Initiates | → Underperform | Get Alert |
| 10/14/2024 | Buy Now | 5.43% | Redburn Atlantic | Jamie Clark44% | → $151 | Initiates | → Sell | Get Alert |
| 10/07/2024 | Buy Now | 32.66% | Evercore ISI Group | Ross Muken52% | $225 → $190 | Downgrade | Outperform → In-Line | Get Alert |
| 10/02/2024 | Buy Now | 50.12% | B of A Securities | Derik De Bruin84% | $250 → $215 | Downgrade | Buy → Neutral | Get Alert |
| 10/01/2024 | Buy Now | 22.19% | Citigroup | Patrick Donnelly80% | $215 → $175 | Downgrade | Neutral → Sell | Get Alert |
| 09/20/2024 | Buy Now | 32.66% | Baird | Eric Coldwell80% | $191 → $190 | Maintains | Neutral | Get Alert |
| 08/12/2024 | Buy Now | 41.74% | TD Cowen | Charles Rhyee36% | $228 → $203 | Maintains | Hold | Get Alert |
| 08/08/2024 | Buy Now | 46.63% | Barclays | Luke Sergott51% | $230 → $210 | Maintains | Equal-Weight | Get Alert |
| 08/08/2024 | Buy Now | 67.57% | UBS | Dan Brennan62% | $290 → $240 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | 57.1% | Evercore ISI Group | Ross Muken52% | $265 → $225 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | 74.56% | Goldman Sachs | Matthew Sykes62% | $290 → $250 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | 43.14% | JP Morgan | Casey Woodring27% | $270 → $205 | Downgrade | Overweight → Neutral | Get Alert |
| 08/08/2024 | Buy Now | 33.36% | Baird | Eric Coldwell80% | $239 → $191 | Downgrade | Outperform → Neutral | Get Alert |
| 07/10/2024 | Buy Now | 66.88% | Baird | Eric Coldwell80% | $271 → $239 | Maintains | Outperform | Get Alert |
| 06/28/2024 | Buy Now | 60.59% | Barclays | Luke Sergott51% | → $230 | Initiates | → Equal-Weight | Get Alert |
| 06/28/2024 | Buy Now | — | Argus Research | David Toung69% | — | Downgrade | Buy → Hold | Get Alert |
| 06/07/2024 | Buy Now | 64.08% | Mizuho | Ann Hynes85% | → $235 | Initiates | → Neutral | Get Alert |
| 06/06/2024 | Buy Now | 102.49% | Goldman Sachs | Matthew Sykes62% | → $290 | Initiates | → Buy | Get Alert |
| 05/13/2024 | Buy Now | 59.2% | TD Cowen | Charles Rhyee36% | $260 → $228 | Maintains | Hold | Get Alert |
| 05/10/2024 | Buy Now | 88.52% | Baird | Eric Coldwell80% | $282 → $270 | Maintains | Outperform | Get Alert |
| 03/18/2024 | Buy Now | 102.49% | Argus Research | David Toung69% | $240 → $290 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | 95.5% | JP Morgan | Casey Woodring27% | $270 → $280 | Maintains | Overweight | Get Alert |
| 02/15/2024 | Buy Now | 85.03% | Evercore ISI Group | Ross Muken52% | $260 → $265 | Maintains | Outperform | Get Alert |
| 02/15/2024 | Buy Now | 102.49% | UBS | Dan Brennan62% | $270 → $290 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | 74.56% | Citigroup | Patrick Donnelly80% | $215 → $250 | Maintains | Neutral | Get Alert |
| 02/15/2024 | Buy Now | 87.12% | Baird | Eric Coldwell80% | $252 → $268 | Maintains | Outperform | Get Alert |
| 02/15/2024 | Buy Now | — | Guggenheim | Sandy Draper73% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/20/2023 | Buy Now | 88.52% | JP Morgan | Casey Woodring27% | $210 → $270 | Maintains | Overweight | Get Alert |
| 12/11/2023 | Buy Now | 50.12% | Citigroup | Patrick Donnelly80% | $190 → $215 | Maintains | Neutral | Get Alert |
| 11/10/2023 | Buy Now | 43.14% | Morgan Stanley | Ricky Goldwasser79% | $220 → $205 | Maintains | Equal-Weight | Get Alert |
| 11/09/2023 | Buy Now | 50.12% | UBS | Dan Brennan62% | $250 → $215 | Maintains | Buy | Get Alert |
| 10/24/2023 | Buy Now | 53.61% | Morgan Stanley | Ricky Goldwasser79% | $235 → $220 | Maintains | Equal-Weight | Get Alert |
| 09/25/2023 | Buy Now | 45.93% | TD Cowen | Charles Rhyee36% | $212 → $209 | Maintains | Market Perform | Get Alert |
| 09/22/2023 | Buy Now | 78.75% | Baird | Eric Coldwell80% | $267 → $256 | Maintains | Outperform | Get Alert |
| 09/22/2023 | Buy Now | 57.1% | Guggenheim | Sandy Draper73% | $255 → $225 | Maintains | Buy | Get Alert |
| 09/22/2023 | Buy Now | 92.01% | Wells Fargo | Timothy Daley54% | $280 → $275 | Maintains | Overweight | Get Alert |
| 09/13/2023 | Buy Now | 48.02% | TD Cowen | Charles Rhyee36% | → $212 | Initiates | → Market Perform | Get Alert |
| 08/10/2023 | Buy Now | 74.56% | JP Morgan | Casey Woodring27% | $225 → $250 | Maintains | Overweight | Get Alert |
| 08/10/2023 | Buy Now | 71.07% | B of A Securities | Derik De Bruin84% | $235 → $245 | Maintains | Buy | Get Alert |
| 07/11/2023 | Buy Now | 57.1% | Citigroup | Patrick Donnelly80% | $260 → $225 | Downgrade | Buy → Neutral | Get Alert |
| 07/10/2023 | Buy Now | 57.1% | Citigroup | Patrick Donnelly80% | $260 → $225 | Downgrade | Buy → Neutral | Get Alert |
| 05/15/2023 | Buy Now | 57.1% | Morgan Stanley | Ricky Goldwasser79% | $230 → $225 | Maintains | Equal-Weight | Get Alert |
| 05/12/2023 | Buy Now | 78.05% | Credit Suisse | Dan Leonard54% | $260 → $255 | Maintains | Outperform | Get Alert |
| 05/12/2023 | Buy Now | 95.5% | Wells Fargo | Timothy Daley54% | $290 → $280 | Maintains | Overweight | Get Alert |
| 03/28/2023 | Buy Now | 41.74% | Jefferies | David Windley74% | $233 → $203 | Maintains | Hold | Get Alert |
| 02/23/2023 | Buy Now | 81.54% | Credit Suisse | Dan Leonard54% | $280 → $260 | Maintains | Outperform | Get Alert |
| 02/23/2023 | Buy Now | 60.59% | Morgan Stanley | Ricky Goldwasser79% | $241 → $230 | Maintains | Equal-Weight | Get Alert |
| 02/23/2023 | Buy Now | 81.54% | Citigroup | Patrick Donnelly80% | $280 → $260 | Maintains | Buy | Get Alert |
| 02/23/2023 | Buy Now | 78.05% | Guggenheim | Sandy Draper73% | → $255 | Upgrade | Neutral → Buy | Get Alert |
| 01/12/2023 | Buy Now | — | Jefferies | David Windley74% | — | Downgrade | Buy → Hold | Get Alert |
| 01/11/2023 | Buy Now | 98.99% | Baird | Eric Coldwell80% | $275 → $285 | Maintains | Outperform | Get Alert |
| 11/03/2022 | Buy Now | 92.01% | JP Morgan | Casey Woodring27% | $280 → $275 | Maintains | Overweight | Get Alert |
| 11/03/2022 | Buy Now | 95.5% | Credit Suisse | Dan Leonard54% | $285 → $280 | Maintains | Outperform | Get Alert |
| 11/03/2022 | Buy Now | 68.27% | Morgan Stanley | Ricky Goldwasser79% | $250 → $241 | Maintains | Equal-Weight | Get Alert |
| 09/30/2022 | Buy Now | 67.57% | Jefferies | David Windley74% | → $240 | Upgrade | Hold → Buy | Get Alert |
| 08/25/2022 | Buy Now | 98.99% | Credit Suisse | Katie Tryhane49% | → $285 | Initiates | → Outperform | Get Alert |
| 08/16/2022 | Buy Now | 109.47% | Wells Fargo | Timothy Daley54% | $325 → $300 | Maintains | Overweight | Get Alert |
| 08/04/2022 | Buy Now | 74.56% | Morgan Stanley | Tejas Savant50% | $350 → $250 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/14/2022 | Buy Now | 102.49% | Deutsche Bank | Justin Bowers46% | $350 → $290 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Charles River (CRL) stock?
The latest price target for Charles River (NYSE:CRL) was reported by Redburn Atlantic on May 23, 2025. The analyst firm set a price target for $182.00 expecting CRL to rise to within 12 months (a possible 27.08% upside). 39 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Charles River (CRL)?
The latest analyst rating for Charles River (NYSE:CRL) was provided by Redburn Atlantic, and Charles River upgraded their buy rating.
When was the last upgrade for Charles River (CRL)?
The last upgrade for Charles River Laboratories International Inc happened on May 23, 2025 when Redburn Atlantic raised their price target to $182. Redburn Atlantic previously had a neutral for Charles River Laboratories International Inc.
When was the last downgrade for Charles River (CRL)?
The last downgrade for Charles River Laboratories International Inc happened on March 21, 2025 when Goldman Sachs changed their price target from $190 to $170 for Charles River Laboratories International Inc.
When is the next analyst rating going to be posted or updated for Charles River (CRL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Charles River, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Charles River was filed on May 23, 2025 so you should expect the next rating to be made available sometime around May 23, 2026.
Is the Analyst Rating Charles River (CRL) correct?
While ratings are subjective and will change, the latest Charles River (CRL) rating was a upgraded with a price target of $188.00 to $182.00. The current price Charles River (CRL) is trading at is $143.22, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
